drugset / Trial / NCT04023149
Efficacy of Interleukin-2 Gargle in the Treatment of Oral Mucosa Lesion in Pemphigus Vulgaris
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This clinical study will test the short-term efficacy of interleukin-2 gargle combined with systemic use of glucocorticoids in the treatment of oral mucosal lesions in mucosal-dominant pemphigus vulgaris and moderate mucocutaneous pemphigus vulgaris.
Timeline
- Start
- 2020-04-02
- Primary completion
- 2021-06-01
- Completion
- 2021-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Recombinant Human Interleukin-2 | Protein / enzyme biologic | 2e+06 iu | Other |